Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to broadly improve tissue function by targeting mechanisms of aging with the ultimate aim of adding 10 years to healthy human lifespan.
We’re building a mission-driven team of accomplished and kind individuals who embrace our startup culture of rapid iteration, transparency, and versatility.
Retro received the accreditation of Retro College of Woolf University and theRetro PhD program in 2024. Retro’s PhD is an accelerated 3-year program. As a fellow, you will support and lead aging research projects in the Tissue Reprogramming team, progressing through key milestones designed to prepare you for a scientist role.
If you are extremely motivated and have a strong desire to learn while also being a high-impact team member, you might be a Retro fellow. As a Retro fellow, you’ll gain exposure to a fast-paced startup environment and work under the guidance of the world’s leading scientists in the field. You’ll have access to all the resources of a well-funded company and the ability to accelerate your learning, as well as your experimentation volume.
The Tissue Reprogramming team is to develop reprogramming-based gene therapies for patients with age-related diseases, with the goal of restoring tissue function and resilience, and ultimately to extend these therapies to broader aging populations to promote healthy aging. By leveraging partial reprogramming to reset age-associated epigenetic states, we aim to address multiple molecular and cellular drivers of age-related dysfunction simultaneously, creating a platform with broad therapeutic potential across age-related diseases.